Alfonso Colorado Casado de Amezua | Medicine and Health Sciences | Forensic Science Communication Award

Published on by Forensic Scientist

Mr. Alfonso Colorado Casado de Amezua | Medicine and Health Sciences | Forensic Science Communication Award

Institute of Legal Medicine and Forensic Sciences of Valencia | Spain

Mr. Alfonso Colorado Casado de Amezúa is a highly respected forensic physician whose career demonstrates a profound commitment to advancing forensic science, medico-legal education, and public communication of specialized knowledge. Currently serving as Director of the Institute of Legal Medicine and Forensic Sciences of Valencia, he has built a distinguished professional record over more than fifteen years, holding key roles across Spain in Catalonia, Albacete, Cuenca, Guadalajara, and Valencia. His leadership has been pivotal in forensic pathology and disaster victim identification, where he has developed and applied protocols for managing mass casualty events with precision and compassion. Alongside his clinical and administrative responsibilities, Mr. Alfonso Colorado Casado de Amezúa has played a central role in training the next generation of forensic professionals. As adjunct professor at the University CEU-Cardenal Herrera in Valencia and Castellón, and as lecturer in numerous specialized courses for forensic doctors, law enforcement, and emergency response teams, he has demonstrated an exceptional ability to communicate complex forensic concepts with clarity and authority. His scientific contributions, including publications in the Revista Española de Medicina Legal and CorSalud, have provided valuable insights into sudden cardiac death and forensic practices in disaster contexts, strengthening both research and applied forensic work. As organizer and speaker in national training programs, he has further enhanced the visibility of forensic medicine and ensured the dissemination of best practices across Spain. By uniting research, practice, and communication, Mr. Colorado embodies the mission of forensic science to serve justice and society, making him an outstanding nominee for the Forensic Science Communication Award.

Profile: ORCID

Featured Publications

Colorado Casado de Amezúa, A., Garrido-Lestache López-Belmonte, E., & Giner Blasco, J. (2025). Medical forensic response during the flood in Valencia (Spain), October 29th, 2024 [Actuación médico-forense durante la riada en Valencia (España) el 29 de octubre de 2024]. Revista Española de Medicina Legal. Advance online publication.

Colorado, A., & Fernández Bayón, J. (2009). Síndrome de Loeys-Dietz. Diagnóstico diferencial en muerte súbita por disección aórtica. Revista Española de Medicina Legal, 35(2), 67–71.

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Sonja Jahnke | Medicine and Health Sciences | Young Scientist Award

Published on by Forensic Scientist

Ms. Sonja Jahnke | Medicine and Health Sciences | Young Scientist Award

Group Practice Drs. Jahnke | Germany

Ms. Sonja Jahnke is a promising young physician-scientist whose academic trajectory reflects an exceptional blend of clinical excellence, research productivity, and international engagement in orthopaedics and sports medicine. She completed her medical education at Brandenburg Medical School (MHB), complemented by clinical rotations at Ludwig Maximilian University, University Hospital Brandenburg, and St. Vinzenz Hospital, where she gained comprehensive training in internal medicine, trauma care, orthopaedics, and sports orthopaedics. Since July 2025, she has been serving as a resident physician in training, advancing her clinical expertise while building upon her earlier role as a surgical assistant at Sporthopaedicum Berlin. Her research focuses on anterior cruciate ligament (ACL) reconstruction, rehabilitation strategies, and the influence of bracing and muscular strength on functional recovery, bridging biomechanics with patient-centered outcomes. Ms. Sonja Jahnke has authored three peer-reviewed publications indexed in Scopus, with 34 citations across 34 documents and an h-index of 2, reflecting her growing scholarly impact. Her contributions have appeared in leading journals such as the Journal of Clinical Medicine (2025), Sports Orthopaedics and Traumatology (2023), Efort Open Reviews (2023), and Healthcare Basel (2023), advancing knowledge on ACL rehabilitation, orthopaedic outcomes, and innovative treatment approaches. In addition, she has delivered invited presentations at prestigious international meetings, including ESSKA 2024 in Milan and the Berlin Arthroscopy Course, underscoring her recognition as a dynamic and insightful communicator. Her achievements have been further acknowledged with the Young Investigator Award from Brandenburg Medical School in 2022, highlighting her strong potential as an emerging leader in sports medicine research and clinical practice.

Profile: Scopus

Featured Publications

  1. Jahnke, S., Prill, R., Królikowska, A., & Becker, R. (2025, September). Test learning effects influence coordinative but not strength-related tasks in patients six months after anterior cruciate ligament reconstruction.

  2. Prill, R., Cruysen, C., Jahnke, S., & Becker, R. (2023, June). Der Einfluss von Bandagen und Orthesen auf die Performance in der Back in Action Testbatterie. Conference Paper.

  3. Diquattro, E., Jahnke, S., Traina, F., & Kopf, S. (2023, May). ACL surgery: Reasons for failure and management.

  4. Jahnke, S., Cruysen, C., Prill, R., & Becker, R. (2023, February). Protocol for a randomized crossover trial to evaluate the effect of soft brace and rigid orthosis on performance and readiness to return to sport six months post-ACL-reconstruction.

  5. Jahnke, S., Becker, R., Królikowska, A., & Prill, R. (2022, August). Manual estimation of hip abductor strength – A practical alternative to conventional assessment tools? Conference Paper.

  6. Jahnke, S., Królikowska, A., Becker, R., & Prill, R. (2022, August). Influence of hip abductor strength on pelvis and knee position during a single-leg landing test. Conference Paper.

  7. Rinaldi, V. G., Prill, R., Jahnke, S., & Becker, R. (2022, August). The influence of gluteal muscle strength deficits on dynamic knee valgus: A scoping review.

Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Prof. Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Wannan Medical College | China

Prof. Zhiliang Xu, affiliated with Wannan Medical College, Wuhu, China, is a distinguished molecular biologist and epigenetics researcher whose work focuses on histone ubiquitination, chromatin remodeling, and their implications in neurological disorders, cancer, gametogenesis, and cellular reprogramming. He earned his Ph.D. from the State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences in 2017. According to Scopus, Prof. Zhiliang Xu has authored 11 publications, which have been cited 34 times, and he holds an h-index of 4, demonstrating the impact of his research in the scientific community. His seminal studies elucidated the role of H2B ubiquitination in chromatin relaxation during meiosis and cellular reprogramming, published in journals such as Nucleic Acids Research (2016), Cell Proliferation (2021), and Reproduction (2017). His recent work on neuronal repair, gut-liver axis regulation in diabetes, and genomic approaches to thalassemia has been featured in FASEB Journal (2025), Annals of Hematology (2025), and Neuroscience Letters (2025). Prof. Zhiliang Xu leads multiple high-impact national and provincial research projects, serves as a peer reviewer for journals including Scientific Reports and Neurochemical Research, and evaluates theses for graduate and doctoral candidates. Recognized with the 2021 National Maternal and Child Health Science and Technology Award (First Prize), the 2022 Guangzhou High-level Talent Award, and the 2024 Outstanding Young Talent honor in Anhui Province, Prof. Zhiliang Xu continues to advance fundamental understanding of chromatin biology and epigenetic regulation, exemplifying excellence, mentorship, and translational scientific impact, making him an outstanding candidate for the Best Researcher Award.

Profile: Scopus | ORCID

Featured Publications

1. Shi, L., Yan, X., Xia, Y., Zhao, Y., Zhu, X., Li, Q., & Xu, Z. (2025). Beyond transfusions and transplants: Genomic innovations rewriting the narrative of thalassemia. Annals of Hematology.

2. Zhang, Y., Wang, J., Huang, S., Liu, M., Zhao, Y., Xu, Z., & Zhu, X. (2025). Electroacupuncture preconditioning alleviates cortical neuronal injury in cerebral ischemia-reperfusion by rebalancing HES1 and NF-κB expression. Neuroreport.

3. Yan, X., Shi, L., Zhu, X., Zhao, J., Zhao, Y., Luo, J., Li, Q., & Xu, Z. (2025). From microbial homeostasis to systemic pathogenesis: A narrative review on gut flora’s role in neuropsychiatric, metabolic, and cancer disorders. Journal of Inflammation Research.

4. Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025). Neurodegenerative diseases and neuroinflammation-induced apoptosis. Open Life Sciences.

5. Li, Q., Zhang, L., Sun, Y., Du, Z., Xu, S., Wang, X., Wei, S., Tao, Y., Li, B., Jiang, J., Di, G., Huang, Y., & Xu, Z. (2025). p53 modulates the gut-liver axis via PI3K/AKT/Wnt signaling pathways in type 2 diabetes. FASEB Journal.

6. Li, Q., Yan, X., Zhao, Y., Xu, Z., & Zhu, X. (2025). Paeonol mitigates chronic stress-induced amygdalar neuronal damage through glycogen synthase kinase-3β/calcineurin axis regulation of synaptic plasticity. Neuroreport.

7. Zhu, X., Zhang, Y., Yan, X., Zhao, Y., Shi, L., Sun, Z., Meng, K., Zong, Y., Li, Q., & Xu, Z. (2025). Paeonol facilitates the repair of neuronal damage in the mPFC caused by chronic stress via the Rho GTPases-cofilin1 signaling pathway. Neuroscience Letters, 138329.

Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

University Hospital Basel | Switzerland

Dr. Andrej Sirek is a dedicated Pathology Resident at the University Hospital Basel, Institute of Medical Genetics and Pathology, where he is actively shaping his career at the intersection of clinical diagnostics and medical research. With his educational foundation built in leading European institutions, Dr. Andrej Sirek has developed a strong grounding in medical genetics, histopathology, and laboratory sciences, which now supports his dual role as both clinician and researcher. His residency provides him with exposure to complex pathology cases while also allowing him to engage in research that seeks to bridge genetic profiling and diagnostic pathology, with the long-term aim of contributing to precision medicine and early disease detection. Currently, he has completed one research project and is progressing with another, both expected to yield indexed publications in the near future. Despite being at an early stage of his academic career, his commitment to innovation in pathology has already been recognized with a nomination for the Best Researcher Award. He maintains active membership in several professional organizations, including SGPATH, ÖGPATH, SGZ, and ESP, which strengthens his global collaborations and engagement with the wider pathology community. While he has yet to publish peer-reviewed articles, his ongoing research demonstrates his potential to make impactful contributions to the field. His academic and professional journey underscores the promise of a new generation of clinician-scientists who integrate advanced diagnostic techniques with research innovation to improve patient care. Dr. Andrej Sirek’s trajectory highlights his dedication, scholarly potential, and commitment to excellence in pathology and medical genetics.

Profile: ORCID

Featured Publications

Dr. Andrej Sirek has contributed to impactful research in pathology, focusing on diagnostic innovations, tumor biology, and clinicopathological correlations. Key recent publications include:

Sirek, A., Hench, I. B., Hench, J., Alborelli, I., Gross, M. W., Jakscha, J., Schaller, P., Nagel, G., Baumhoer, D., & Tzankov, A. (2025). Recurrent clonal radiotherapy-associated fibroepithelial polyp of the pharynx: Do low grade radiogenic stromal tumours exist? Case report.

Sobottka, B., Vetter, V., Banaei-Esfahani, A., Nowak, M., Lorch, A., Sirek, A., Mertz, K. D., Brunelli, M., Berthold, D., de Leval, L., et al. (2024). Immune phenotype-genotype associations in primary clear cell renal cell carcinoma and matched metastatic tissue.

Nitika Dhingra | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Dr. Nitika Dhingra | Health Professions | Best Researcher Award

Chitkara University | India

Dr. Nitika Dhingra  is an academic and researcher at Chitkara University, Punjab, India, with expertise in machine learning–integrated sensor development, non-destructive spectroscopy, and RF-based sensing technologies. She holds a Ph.D. in Electronics and Communication Engineering from Chitkara University, supported by an M.Tech from Punjabi University and a B.Tech from Punjab Technical University. Her research advances applications in food adulteration detection, construction material classification, and structural health monitoring of heritage sites. She has contributed significantly as a Junior and Senior Research Fellow under a DST-SHRI scheme, focusing on sensor design, embedded systems, and machine learning integration. In 2024, she secured a DST-funded research grant worth 27 Lakhs as Principal Investigator, demonstrating her leadership in high-impact projects. Her scholarly contributions include 12 publications indexed in Scopus, 9 citations across 8 documents, and an h-index of 2, along with several granted and filed patents. She has been honored with the Gandhian Young Technological Innovation Award, DST Senior Research Fellowship, and the Best Paper Presentation Award at ICAMSE, and was a semi-finalist in the DST–Texas Instruments Innovation Challenge. Dr. Nitika Dhingra’s career exemplifies innovation, academic excellence, and impactful contributions to science and technology.

Profile: Scopus

Featured Publications

  • Dhingra, N., Saluja, N., Garg, R., & Kanwar, V. (2023). Radio frequency as a non-destructive approach to concrete structure health monitoring. Iranian Journal of Science and Technology, Transactions of Civil Engineering. Cited by: 3.

  • Dhingra, N., Ghosh, D., Saluja, N., & Sabapathay, T. (2023). Radio frequency based sensor for adulteration measurement in a continuous two phase-flow of alcoholic beverages. Sensing and Imaging, 24(1), 32. Cited by: 2.

  • Dhingra, N., Saluja, N., Kanwar, V., & Garg, R. (2021). Moisture sensitive electrical property measurement in concrete slab with step graded antenna. Materials Today: Proceedings, 45, 5172–5176. Cited by: 2.

  • Dhingra, N., & Saluja, N. (2024). RF sensor-based adulterant discriminant estimation in mustard oil. Sensing and Imaging, 25(1), 59. Cited by: 1.

  • Dhingra, N., & Saluja, N. (2024). A novel non-destructive technique-based automated classification of construction material using machine learning. Asian Journal of Civil Engineering, 25(1), 805–810. Cited by: 1.

  • Geetanjali, Jindal, P., Saluja, N., Kashyap, N., & Dhingra, N. (2023). Design and optimization of wideband RF energy harvesting antenna for low-power wireless sensor applications. Proceedings of International Conference on Data Science and Applications. Cited by: 1.

Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Published on by Forensic Scientist

Dr. Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Endocrine and Metabolism Research Center | Iran

Dr. Fatemeh Shirani is a distinguished scholar in the field of Nutritional Sciences, renowned for her groundbreaking contributions to clinical nutrition, dietary epidemiology, and metabolic health. She has consistently advanced the understanding of how diet and nutrition influence chronic disease prevention and treatment, with a strong emphasis on obesity, diabetes, and cardiovascular disease. Through her innovative research and global collaborations, she has established herself as a thought leader whose work bridges scientific evidence with practical dietary strategies for public health. Currently serving at the Endocrine and Metabolism Research Center of Isfahan University of Medical Sciences, she has become a role model for women in science through her dedication, mentorship, and international engagement.

Professional Profile

Google Scholar

ORCID

Education

Dr. Fatemeh Shirani completed her academic journey with distinction in Nutritional Sciences, earning her foundational and advanced degrees from leading Iranian institutions. She further enriched her expertise through doctoral-level research at Ahvaz Jundishapur University of Medical Sciences, where she focused on the intricate links between nutrition and chronic diseases. Her academic training was complemented by international research at Victoria University in Melbourne, Australia, where she deepened her skills in nutritional biomedicine and clinical research methodologies. This comprehensive educational background provided her with a strong platform to integrate theoretical knowledge with practical application in clinical and population-based nutrition research.

Experience

Dr. Fatemeh Shirani has accumulated extensive experience across research, teaching, and scientific service. She has contributed to large-scale community-based projects, such as national nutrition surveys and heart health programs, aimed at improving public health outcomes through evidence-based interventions. As a dedicated educator, she has taught undergraduate and graduate students, instilling in them the principles of basic nutrition, clinical dietetics, and community health. Her expertise extends to laboratory techniques such as PCR and cell culture, which she has applied to translational nutrition studies. Beyond academia, she has actively participated as a reviewer for prestigious international journals, shaping the quality of published science in her field. Her professional journey reflects a balance of teaching, research, community service, and scientific leadership.

Research Interests

Dr. Fatemeh Shirani’s research interests lie at the intersection of nutrition, epidemiology, and chronic disease management. She is deeply invested in exploring obesity and weight-loss strategies, nutritional interventions for diabetes and metabolic disorders, and the role of diet in preventing cardiovascular disease. Her work also investigates the emerging field of “infectobesity,” examining the connections between viral infections and obesity. By employing systematic reviews, meta-analyses, and clinical trials, she provides high-quality evidence that informs dietary recommendations and policy guidelines. Her studies not only address the biological mechanisms of nutrition-related diseases but also emphasize the translation of findings into practical interventions for populations at risk.

Awards

Dr. Fatemeh Shirani has been widely recognized for her contributions to nutritional sciences, particularly her ability to merge clinical expertise with public health perspectives. Her nomination for the Women Researcher Award reflects her outstanding achievements in advancing women’s representation in scientific leadership and her sustained impact on global nutrition research. She has consistently demonstrated excellence through her publications, conference presentations, and active participation in national and international nutrition societies. This recognition highlights not only her scientific accomplishments but also her commitment to mentoring young researchers and fostering collaborative networks across borders.

Publication

Dr. Fatemeh Shirani has produced a rich body of work that has been widely cited in international literature. Selected publications include:

Title: Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases incidence: a systematic review and meta-analysis
Journal: Nutrition
Published on: 2013
Citation: 482

Title: The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta‐analysis of randomized controlled trials
Journal: Obesity Reviews
Published on: 2016
Citation: 308

Title: Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials
Journal: Nutrition
Published on: 2013
Citation: 288

Title: The role of magnesium in sleep health: a systematic review of available literature
Journal: Biological Trace Element Research
Published on: 2023
Citation: 104

Title: Is phase angle a valuable prognostic tool in cancer patients’ survival? A systematic review and meta-analysis of available literature
Journal: Clinical Nutrition
Published on: 2021
Citation: 98

Title: Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis of clinical trials
Journal: Diabetes Research and Clinical Practice
Published on: 2017
Citation: 95

Title: Effects of concentrated pomegranate juice on subclinical inflammation and cardiometabolic risk factors for type 2 diabetes: A quasi-experimental study
Journal: International Journal of Endocrinology and Metabolism
Published on: 2016
Citation: 55

Conclusion

In conclusion, Dr. Fatemeh Shirani stands as a leading figure in nutritional sciences whose contributions have advanced both research and practice in the prevention and management of chronic diseases. Her ability to translate complex scientific findings into practical dietary strategies has had a lasting impact on public health. With her strong publication record, global collaborations, and dedication to mentorship, she exemplifies the qualities of an outstanding woman researcher. Her nomination for the Women Researcher Award reflects not only her academic excellence but also her leadership, vision, and commitment to improving health outcomes through nutrition science.

Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Published on by Forensic Scientist

Dr. Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Sandikli State Hospital | Turkey

Dr. Begum Ertan is an accomplished medical doctor and specialist in Gynecology and Obstetrics, serving at Afyonkarahisar Sandikli State Hospital. She is recognized for her dedication to advancing women’s reproductive health, blending clinical expertise with a strong commitment to academic research. Her work spans adenomyosis diagnosis, infertility treatment, IVF success prediction, and gynecologic oncology. Actively engaged in professional societies, she is a core group member of the Turkish Endometriosis and Adenomyosis Society. Dr. Ertan combines patient-centered care with cutting-edge scientific approaches, striving to improve diagnostic accuracy, treatment outcomes, and overall quality of life for women.

Professional Profile

Scopus

Education

Dr. Ertan completed her medical degree at Celal Bayar University, Faculty of Medicine, where she laid a strong foundation in clinical sciences and patient care. She then specialized in Obstetrics and Gynecology at Dokuz Eylül University, Faculty of Medicine, developing advanced skills in reproductive medicine, maternal-fetal health, and minimally invasive surgical techniques. Her education was enriched by exposure to diverse clinical cases and participation in academic projects, fostering her dual role as a skilled clinician and committed researcher.

Experience

With extensive experience as a Gynecology and Obstetrics Specialist, Dr. Ertan has managed complex cases involving high-risk pregnancies, reproductive endocrinology, and gynecologic surgery. She has contributed to multidisciplinary medical teams, enhancing patient outcomes through evidence-based approaches. Her professional activities include presenting original research at leading national and international conferences, authoring peer-reviewed publications, and writing academic book chapters on endometriosis, infertility, and hormonal therapies. In addition to her hospital duties, she actively participates in community health initiatives, delivering educational seminars on women’s health and hygiene.

Research Interests

Dr. Ertan’s research is driven by a commitment to improving women’s reproductive health through innovative diagnostic and therapeutic methods. She is particularly interested in adenomyosis detection using advanced imaging modalities, identifying predictive factors for IVF success, evaluating the impact of early pregnancy findings on pregnancy outcomes, and exploring rare gynecologic pathologies. Her studies also address the role of hysteroscopic evaluation in abnormal uterine bleeding and the relationship between ovarian conditions and fertility potential. By integrating clinical insight with research innovation, she aims to bridge the gap between academic findings and real-world patient care.

Awards

Dr. Ertan’s professional trajectory reflects the qualities sought in the Young Researcher Award  innovation, dedication, and measurable contributions to the field. Her growing portfolio of scientific publications, her active participation in professional societies, and her involvement in public health education underscore her status as a promising and impactful early-career researcher in obstetrics and gynecology.

Publications

  • Title: Prediction of adenomyosis according to revised definitions of morphological uterus sonographic assessment features
    Journal: Frontiers in Medicine
    Published on: August 2024

  • Title: Comparison of Patients with Adenomyosis Detected in Hysterectomy Material and Patients with Other Benign Pathologies: Retrospective Study
    Journal: Turkish Journal of Reproductive Medicine and Surgery
    Published on: 2024

  • Title: Impact of ovarian cysts observed on the initial day of ovulation induction on the success rates in IVF cycles
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Correlation of adenomyosis risk factors with pathologic diagnosis
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Pregnancy Loss Prediction Based on Early First Trimester Ultrasound
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Ovarian hilus cell hyperplasia and sertoli-leydig cell tumor in a patient with postmenopausal virilization: a rare case report
    Journal: Aegean Journal of Obstetrics and Gynecology
    Published on: December 2021

Conclusion

Dr. Begum Ertan embodies the profile of an emerging leader in reproductive medicine. Her clinical expertise, research productivity, and academic contributions have already made a significant impact on the field. Through her continued work in advanced gynecologic diagnostics, fertility treatment, and women’s health advocacy, she demonstrates exceptional promise as a young researcher. Her commitment to bridging scientific innovation with practical healthcare solutions makes her a strong and deserving candidate for the Young Researcher Award.

Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Hong Kong Baptist University | Hong Kong

Dr. Xuan Zhang is a highly respected Lecturer II at the School of Chinese Medicine, Hong Kong Baptist University. As a registered Chinese Medicine Practitioner in both Mainland China and Hong Kong, she has cultivated a strong academic and clinical foundation rooted in traditional Chinese medicine principles. Since joining HKBU in 2016, she has significantly contributed to teaching, research, and international academic collaborations. Her leadership in evidence-based research, combined with her deep understanding of the Huangdi Neijing and classical theories such as the Five Circuits and Six Qi, positions her as a pioneer in integrating tradition with modern scientific approaches. Dr. Zhang has led or participated in more than 15 externally funded projects and published over 100 peer-reviewed articles, with a strong record of first- and corresponding-author contributions.

Professional Profile

ORCID

Scopus

Education

Dr. Zhang earned her Ph.D. in Chinese Medicine from the prestigious Beijing University of Chinese Medicine. Her doctoral training provided a rich combination of theoretical studies, classical text interpretation, and hands-on clinical applications. The academic environment fostered her early interest in integrating traditional Chinese medical theories with scientific methodologies. Her educational path laid the groundwork for her to pursue rigorous research in both the theoretical foundations and practical applications of Chinese medicine, particularly in the fields of epidemiology, gastrointestinal diseases, and methodological development.

Experience

With close to a decade of academic and clinical teaching experience, Dr. Zhang has taken on numerous roles that extend beyond the classroom. Since joining HKBU in 2016, she has secured seven research grants as Principal Investigator and served as co-investigator in multiple national-level projects funded by organizations such as the National Natural Science Foundation of China and the Chinese Medicine Development Fund (HKSAR). Her expertise has led to contributions in reporting guideline development, multicentre clinical trials, and telemedicine studies. She also serves on editorial boards for international journals such as Scientific Reports, BMC Medical Research Methodology, and the Journal of Traditional Chinese Medical Sciences, underscoring her standing in the academic community.

Research Interests

Dr. Zhang’s core research areas include: (1) theoretical and clinical research based on the Huangdi Neijing, with a focus on the “Five Circuits and Six Qi” (Wu Yun Liu Qi); (2) development of evidence-based Chinese medicine practices and methodological reporting standards; (3) clinical studies on gastrointestinal diseases such as IBS and ulcerative colitis; and (4) epidemiological research in infectious diseases within the framework of Chinese medicine. She has championed multidisciplinary and cross-regional collaborations that explore the integration of data science with ancient medical systems. Her ongoing work also addresses the modernization and standardization of traditional practices to ensure global acceptance and scientific validation.

Awards and Recognition

Dr. Zhang has received numerous awards for her outstanding research and contributions to Chinese medicine. She was named among China’s CNKI Highly Cited Scholars (Top 1%) and received the “Top Cited Article” award in the Journal of Evidence-Based Medicine. She was also honored as one of the “100 Outstanding Reviewers” of the China Journal of Traditional Chinese Medicine and Pharmacy and recognized as the “1st Qiu Zhen Scholars of Chinese Medicine.” Additionally, she earned the “Top Articles in Outstanding S&T Journals of China” award twice and the “Third Prize of Science and Technology Award” from the China Association of Chinese Medicine. These accolades reflect her significant impact on both theoretical and applied Chinese medicine research.

Publications

  1. Title: A Protocol for Developing, Disseminating, and Implementing a Core Outcome Set for Clinical Trials of Integrative Chinese and Western Medicine for Ulcerative Colitis
    Journal: Journal of Integrative Medicine
    Published on: 31 Jul 2025

  2. Title: Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial
    Journal: Phytomedicine
    Published on: Sep 2025

  3. Title: Outcomes reporting in clinical trials of Chinese herbal medicine on ulcerative colitis: A systematic review
    Journal: Journal of Evidence-Based Medicine
    Published on: 28 Oct 2024

  4. Title: Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
    Journal: Frontiers in Medicine
    Published on: 17 Jun 2024

  5. Title: Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions
    Journal: Frontiers of Medicine
    Published on: 17 May 2024

  6. Title: STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT Statement
    Journal: Journal of Evidence-Based Medicine
    Published on: 14 Mar 2023

  7. Title: Reporting assessment of multicenter clinical trial protocols: a cross-sectional study
    Journal: Journal of Evidence-Based Medicine
    Published on: 03 Mar 2023

Conclusion

Dr. Xuan Zhang is a distinguished researcher, educator, and clinical scholar whose work reflects a deep integration of traditional Chinese medicine principles with contemporary clinical and scientific practices. Her extensive publication record, grant leadership, and editorial responsibilities demonstrate her strong research acumen and commitment to globalizing Chinese medicine. With high-impact contributions, international collaborations, and multiple recognitions for academic excellence, Dr. Zhang is a highly deserving candidate for the Best Researcher Award. Her work continues to shape the future of evidence-based Chinese medicine and methodological innovation.

Shoukui Hu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Shoukui Hu | Medicine and Health Sciences | Best Researcher Award

Zhengzhou Central Hospital Affiliated to Zhengzhou University | China

Dr. Shoukui Hu is a distinguished medical microbiologist and molecular biologist currently serving as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital. With over two decades of impactful work in pathogenic biology, Dr. Hu has been instrumental in advancing public health diagnostics and molecular epidemiology in China. His leadership and research contributions have strengthened clinical laboratory practices and disease surveillance.

Author Profile👤

ORCID

Scopus

Strengths for the Awards✨

Dr. Shoukui Hu brings over two decades of experience in pathogenic biology and molecular biology, having contributed significantly to public health and clinical research in China. He currently serves as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital, a role that highlights both his leadership capabilities and clinical expertise. His academic journey, culminating in a Ph.D. from the China CDC, laid a solid foundation for impactful research in infectious diseases, microbiology, and translational diagnostics.

A standout strength is his strong publication record, with at least nine peer-reviewed SCI-indexed articles published in the past five years alone—many as corresponding or first author. These papers cover emerging infectious pathogens such as Candida auris, Helicobacter pylori, Neisseria meningitidis, and Streptococcus pneumoniae, which are critical topics in global public health. His research has been published in high-impact Q1 and Q2 journals such as Gut Microbes, Helicobacter, BMC Genomics, and World Journal of Gastroenterology, demonstrating relevance, innovation, and scientific rigor.

Furthermore, Dr. Hu’s expertise in molecular diagnostics, particularly the development of biosensors and amplification techniques, shows clear translational value, directly impacting clinical diagnostics and public health surveillance systems. His dual expertise in research and hospital management positions him as a bridge between science and clinical application—an invaluable trait for advancing healthcare innovations.

🎓 Education

Dr. Hu began his academic journey with a BSc from Anhui Science and Technology University (1995–1999), followed by an MSc in Microbiology (2001–2004) jointly awarded by the National Institute for Communicable Disease Control and Prevention and Anhui Agricultural University. He then earned his Ph.D. in Pathogeny Biology (2009–2014) from the same institute under the China CDC, equipping him with a deep scientific foundation to drive impactful research.

🧪 Experience

Currently the Senior Technologist and Director at Peking University Shougang Hospital (since 2016), Dr. Hu has also held vital roles such as Postdoctoral Fellow in Molecular Epidemiology at the China CDC (2014–2016) and Associate Senior Technologist at Peking University International Hospital (2014). From 2004 to 2014, he served as Deputy Department Director of the Microbiology Lab at Anhui CDC, where he led several high-level surveillance and diagnostic programs across China.

🔬 Research Interests On Medicine and Health Sciences

Dr. Hu’s research passion lies at the intersection of pathogenic biology and molecular biology. He is particularly focused on Helicobacter pylori infections, gut microbiota, antimicrobial resistance, and the genomic characterization of emerging pathogens. His studies contribute valuable insight into immune mechanisms, pathogen identification, and microbiome-related diseases.

🏆 Awards

While specific awards are not listed in the provided CV, Dr. Hu’s consistent corresponding authorship and leadership in high-impact international publications indicate significant professional recognition. His role in directing laboratory operations at a top-tier hospital and publishing in top Q1 journals further reflects his prestige and contributions to global health science.

📚 Publications

Below are key publications from the past 5 years, with hyperlinks, journal names, years, and citation roles:

  1. Isolation of Fluconazole-Resistant South Asian Clade Candida auris in Beijing, China, American Journal of Tropical Medicine and Hygiene, 2025 – Corresponding Author

  2. Influence of Helicobacter pylori on composition and function of gastric microbiota in patients with chronic non-atrophic gastritis, Heliyon, 2024 – Corresponding Author

  3. The role of toll-like receptors in immune tolerance induced by Helicobacter pylori infection, Helicobacter, 2023 – Corresponding Author

  4. Comparative analysis of the gut microbiota of wild adult rats from nine district areas in Hainan, China, World Journal of Gastroenterology, 2023 – Corresponding Author

  5. Ultra-efficient multiple cross displacement amplification-lateral flow biosensor for serogroup identification of prevalent Neisseria meningitidis, Analytical Biochemistry, 2022 – Corresponding Author

  6. Simultaneous detection of Streptococcus pneumoniae… using multiple cross displacement amplification, FEMS Microbiology Letters, 2021 – Corresponding Author

  7. Hemolysin BL from Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo, Gut Microbes, 2020 – Co-First Author

  8. Genomic analysis of Helicobacter himalayensis sp. nov. isolated from Marmota himalayana, BMC Genomics, 2020 – First Author

  9. Alteration of gut microbiota in type 2 diabetes complicated with cholelithiasis patients, Chinese Medical Journal, 2022 – Corresponding Author

✅ Conclusion

🎖️ Dr. Shoukui Hu is a pioneering clinical researcher and laboratory expert whose work spans epidemiological surveillance, diagnostic innovation, and microbiome science. With a sustained record of leadership, publication, and mentorship, he exemplifies the qualities of a Best Researcher Award nominee. His scholarly output and translational impact make him a key contributor to advancing infectious disease control and laboratory science in China and beyond.